Ticker
INOCompany Name
INOVIO PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Net Income Common Stock | Return on Assets |
---|---|---|---|
6/30/2025 | $ 68.24M | $ -87.76M | -128.61% |
3/31/2025 | $ 87.27M | $ -96.48M | -110.55% |
12/31/2024 | $ 113.2M | $ -107.25M | -94.75% |
9/30/2024 | $ 107.06M | $ -112.88M | -105.43% |
6/30/2024 | $ 133.8M | $ -121.64M | -90.91% |
3/31/2024 | $ 129.11M | $ -124.94M | -96.77% |
12/31/2023 | $ 170.95M | $ -135.12M | -79.04% |
9/30/2023 | $ 193.1M | $ -164.58M | -85.23% |
6/30/2023 | $ 233.04M | $ -168.43M | -72.28% |
3/31/2023 | $ 266.58M | $ -241.39M | -90.55% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Assets
(=) ROA
ROA for INOVIO PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ -179.73M ] / Assets [ $ 437.81M ]
(=) ROA [ -41.05% ]
Minimum
Jun 30, 2025
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.44K |
---|---|
min | -33.4% |
max | 33.98% |
average | 0.12% |
median | 1.53% |
std | 10.61% |